Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new gender-specific model for skin autofluorescence risk stratification. | Sci Rep | 2015 | 25974028 | PubTator, text mining | PubMed |
| PharmGKB summary: Efavirenz pathway, pharmacokinetics. | Pharmacogenet Genomics | 2015 | 25966836 | PubTator, text mining | PubMed |
| N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis. | Antimicrob Agents Chemother | 2015 | 25963985 | PubTator, text mining | PubMed |
| Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma. | Mol Med Rep | 2015 | 25936657 | PubTator, text mining | PubMed |
| MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis. | PLoS One | 2015 | 25915206 | PubTator, text mining | PubMed |
| A method to associate all possible combinations of genetic and environmental factors using GxE landscape plot. | Bioinformation | 2015 | 25914450 | PubTator, text mining | PubMed |
| Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. | Circ Cardiovasc Genet | 2015 | 25901039 | PubTator, text mining | PubMed |
| CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. | BMC Pharmacol Toxicol | 2015 | 25889207 | PubTator, text mining | PubMed |
| Whole genome sequencing of an ethnic Pathan (Pakhtun) from the north-west of Pakistan. | BMC Genomics | 2015 | 25887915 | PubTator, text mining | PubMed |
| Structural and Kinetic Characterization of a Novel N-acetylated Aliphatic Amine Metabolite of the PRMT Inhibitor, EPZ011652. | Drug Metab Dispos | 2015 | 25887455 | PubTator, text mining | PubMed |
| NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study. | BMC Cancer | 2015 | 25886288 | PubTator, text mining | PubMed |
| Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis. | Biomed Res Int | 2015 | 25866762 | PubTator, text mining | PubMed |
| Gene-diet interactions and their impact on colorectal cancer risk. | Curr Nutr Rep | 2015 | 25844273 | PubTator, text mining | PubMed |
| Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms. | World J Gastroenterol | 2015 | 25834322 | PubTator, text mining | PubMed |
| Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake. | J Nutr | 2015 | 25833779 | PubTator, text mining | PubMed |
| Prevalence of glutathione S-transferase M1 null polymorphism in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study. | Contemp Clin Dent | 2015 | 25821378 | PubTator, text mining | PubMed |
| Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice. | Liver Int | 2015 | 25809692 | PubTator, text mining | PubMed |
| N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. | Tumour Biol | 2015 | 25804798 | PubTator, text mining | PubMed |
| Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations. | Drug Metab Pers Ther | 2015 | 25803091 | PubTator, text mining | PubMed |
| Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. | J Clin Invest | 2015 | 25798622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=80